戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  and in disease states such as adhesions and menorrhagia.
2 techniques have emerged for the treatment of menorrhagia.
3 f inherited bleeding disorders in women with menorrhagia.
4 ruising, epistaxis, gingival hemorrhage, and menorrhagia.
5 pproximately 23%) such as oligomenorrhea and menorrhagia.
6 emostasis testing is justified in women with menorrhagia and a normal gynecological evaluation, as 11
7 nd in a substantial proportion of women with menorrhagia and a normal pelvis examination.
8  bleed (three children aged 12-17 years with menorrhagia and one child aged 6-11 years with gingival
9 tion of common gynecologic problems, such as menorrhagia and postmenopausal bleeding.
10 n the frequency of the pathologic causes for menorrhagia and the potential to use new therapies such
11 omiting, diarrhea, epistaxis, bleeding gums, menorrhagia, and melena in humans.
12 r-old woman with recurrent uterine fibroids, menorrhagia, anemia, and fatigue who wishes to retain fe
13 and on the specific assessment of women with menorrhagia are ongoing.
14 in 53 patients (age range, 33-58 years) with menorrhagia, bulk-related symptoms (frequency of urinati
15 ternative, but success rates have varied and menorrhagia can recur.
16 most frequent indication for hysterectomy is menorrhagia, even though the uterus is normal in a large
17 ernative to hysterectomy in the treatment of menorrhagia for many women with no other serious disorde
18 atening bleeding with trauma or surgery, and menorrhagia in affected women.
19                                     Although menorrhagia is a common gynaecological symptom, a specif
20                                              Menorrhagia is a common problem, yet evidence to inform
21                                      Because menorrhagia is a very common clinical condition reported
22                                              Menorrhagia is the most common symptom and the primary i
23 -specific quality of life, measured with the menorrhagia multi-attribute quality of life scale (MMAS)
24 utcome was the patient-reported score on the Menorrhagia Multi-Attribute Scale (MMAS) (ranging from 0
25 leeds, bruising, bleeding from minor wounds, menorrhagia or postpartum bleeding in women as well as b
26  history of mental disorders, endometriosis, menorrhagia, polycystic ovary syndrome, dysmenorrhea, le
27 bleeding, petechiae, and purpura; (2) severe menorrhagia resulting in anemia and need for whole-blood
28                                              Menorrhagia since menarche was noted in 11 (8.9%) of 123
29          We randomly assigned 571 women with menorrhagia to treatment with levonorgestrel-IUS or usua
30  February 1998, 894 women with uncomplicated menorrhagia were recruited from 6 hospitals in southwest
31                   202 women with symptomatic menorrhagia were recruited to a multicentre, randomised,
32 re but potentially life-threatening cause of menorrhagia which must be kept in the differential diagn
33                 The patient had a history of menorrhagia, which was managed with oral contraceptive u
34                                In women with menorrhagia who presented to primary care providers, the
35 ) with usual medical treatment in women with menorrhagia who presented to their primary care provider
36          Women referred for investigation of menorrhagia whose pelvis was normal on clinical examinat